Product Overview
[Drug Name]
Generic Name: Clopidogrel Bisulfate Tablets
Trade Name: Revison Clopidogrel Bisulfate Tablets 75mg x 7 tablets
[Main Ingredients]
Clopidogrel bisulfate.
[Properties]
Clopidogrel bisulfate tablets (Encun) are pink, round, film-coated tablets with "111" engraved on one side. After removal of the coating, they appear white or off-white.
[Indications/Main Functions]
For the prevention of atherothrombotic events in the following patients: myocardial infarction (from a few days to less than 35 days), ischemic stroke (from 7 days to less than 6 months), or patients with established peripheral arterial disease. For patients with acute coronary syndrome, non-ST-segment elevation acute coronary syndrome (including unstable angina or non-Q-wave myocardial infarction), including patients with stent implantation after percutaneous coronary intervention, in combination with aspirin. For patients with ST-segment elevation acute coronary syndrome, in combination with aspirin, and can be used in conjunction with thrombolytic therapy.
[Specifications]
75mg*7 tablets
[Dosage and Administration]
Adults and Elderly: Generally, the recommended dosage for adults is 75mg once daily orally. However, depending on age, weight, and symptoms, a 50mg dose may be administered once daily, with or without food.
[Adverse Reactions]
Occasional gastrointestinal reactions (e.g., abdominal pain, indigestion, constipation, or diarrhea), rash, and mucocutaneous bleeding may occur. Rarely, leukopenia and granulocytopenia may occur.
[Contraindications]
1. Patients with hypersensitivity to the active substance or any of the ingredients in this product should not use Encun Clopidogrel Bisulfate Tablets.
2. Severe liver damage.
3. Active pathological bleeding, such as peptic ulcer or pathological bleeding.
4. Breastfeeding.
[Precautions]
See package insert for details.
